The Neurocognition of Developmental Disorders of Language.

articulation disorder basal ganglia childhood apraxia of speech declarative memory developmental language disorder dyslexia procedural circuit deficit hypothesis procedural memory specific language impairment stuttering

Journal

Annual review of psychology
ISSN: 1545-2085
Titre abrégé: Annu Rev Psychol
Pays: United States
ID NLM: 0372374

Informations de publication

Date de publication:
04 01 2020
Historique:
pubmed: 25 7 2019
medline: 27 10 2020
entrez: 25 7 2019
Statut: ppublish

Résumé

Developmental disorders of language include developmental language disorder, dyslexia, and motor-speech disorders such as articulation disorder and stuttering. These disorders have generally been explained by accounts that focus on their behavioral rather than neural characteristics; their processing rather than learning impairments; and each disorder separately rather than together, despite their commonalities and comorbidities. Here we update and review a unifying neurocognitive account-the Procedural circuit Deficit Hypothesis (PDH). The PDH posits that abnormalities of brain structures underlying procedural memory (learning and memory that rely on the basal ganglia and associated circuitry) can explain numerous brain and behavioral characteristics across learning and processing, in multiple disorders, including both commonalities and differences. We describe procedural memory, examine its role in various aspects of language, and then present the PDH and relevant evidence across language-related disorders. The PDH has substantial explanatory power, and both basic research and translational implications.

Identifiants

pubmed: 31337273
doi: 10.1146/annurev-psych-122216-011555
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S. Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

389-417

Subventions

Organisme : NIDCD NIH HHS
ID : R21 DC016391
Pays : United States
Organisme : NICHD NIH HHS
ID : R21 HD087088
Pays : United States

Auteurs

Michael T Ullman (MT)

Brain and Language Lab, Department of Neuroscience, Georgetown University, Washington, DC 20057, USA; email: michael@georgetown.edu.

F Sayako Earle (FS)

Department of Communication Sciences and Disorders, University of Delaware, Newark, Delaware 19713, USA.

Matthew Walenski (M)

Department of Communication Sciences and Disorders, Northwestern University, Evanston, Illinois 60208, USA.

Karolina Janacsek (K)

Institute of Psychology, Eotvos Lorand University (ELTE), H-1071 Budapest, Hungary.
Brain, Memory, and Language Lab; Institute of Cognitive Neuroscience and Psychology, Research Centre for Natural Sciences, Hungarian Academy of Sciences, H-1117 Budapest, Hungary.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH